Serveur d'exploration sur la maladie de Parkinson - Analysis (USA)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Pour accéder à une entrée :

Les termes de plus forte occurence

427Parkinson's disease
47Parkinson disease
37levodopa
33genetics
32dementia
31Parkinson’s disease
30deep brain stimulation
29dopamine
28depression
25parkinsonism
23epidemiology
22Alzheimer's disease
19LRRK2
18Parkinson
17subthalamic nucleus
16neuroprotection
16dyskinesia
15cognition
14multiple system atrophy
14gait
14essential tremor
13neurodegeneration
13Wolff‐Parkinson‐White syndrome
13MPTP
12tremor
12treatment
12rating scales
11α‐synuclein
11substantia nigra
11motor fluctuations
11motor complications
11UPDRS
10quality of life
10atrial fibrillation
10Parkinsonism
10Lewy bodies
10Alzheimer disease
9psychosis
9oxidative stress
9olfaction
9mutation
9hallucinations
9diagnosis
9basal ganglia
9alpha‐synuclein
9PET
9Dopamine
8risk factors
8rasagiline
8progressive supranuclear palsy
8positron emission tomography
8mitochondria
8elderly
8dopamine agonists
8dopamine agonist
8cognitive impairment
7smoking
7dyskinesias
7clinimetrics
7clinical trial
7arrhythmia
7PINK1
7Levodopa
7Huntington's disease
6supraventricular tachycardia
6parkin
6magnetic resonance imaging
6dystonia
6dementia with Lewy bodies
6clinical trials
6bradykinesia
6accessory pathway
6PD
6Neurodegeneration
6Lewy body
5validity
5transcranial magnetic stimulation
5striatum
5sleep
5postural instability
5neurotoxicity
5neuropathology
5neurodegenerative diseases
5movement disorders
5linkage
5globus pallidus
5freezing of gait
5disability
5association
5anxiety
5Substantia nigra
5Striatum
4wearing‐off
4ventricular tachycardia
4uric acid
4ubiquitin
4tyrosine hydroxylase
4reliability
4psychometrics
4proteasome
4pathophysiology
4nonmotor symptoms
4mortality
4monoamine oxidase
4microglia
4meta‐analysis
4leucine‐rich repeat kinase 2
4human
4glucocerebrosidase
4gait variability
4family history
4falls
4entacapone
4differential diagnosis
4corticobasal degeneration
4constipation
4complex disease
4catheter ablation
4biomarkers
4apathy
4anticholinergics
4amantadine
4aging
4Unified Parkinson's Disease Rating Scale
4TH
4SNP
4SNCA
4Parkinson's
4PRKN
4MRI
4Gaucher disease
4Disorders of the nervous system
4Deep brain stimulation
4Alzheimer’s disease
46‐hydroxydopamine
41-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
3visual hallucinations
3ubiquitin‐proteasome system
3therapy
3test–retest reliability
3systematic review
3synuclein
3sudden death
3substantia nigra pars compacta
3sleep disorders
3selegiline
3safety
3restless legs syndrome
3quetiapine
3progression
3preexcitation
3pramipexole
3placebo
3physical therapy
3parkinson's disease
3pallidotomy
3pain
3neurosurgery
3neuropsychology
3neuropsychiatry
3neuroinflammation
3morbidity
3monotherapy
3monoamine oxidase inhibitors
3mitochondrial DNA
3mild cognitive impairment
3manganese
3linkage disequilibrium
3kinase
3health‐related quality of life
3gene transfer
3gene therapy
3gambling
3functional magnetic resonance imaging
3function
3familial Parkinson's disease
3experimental therapeutics
3evidence‐based medicine
3electrophysiology
3electrocardiogram
3dysphagia
3dopaminergic neurons
3dopamine transporter
3disease progression
3disease modification
3diagnostic criteria
3coffee
3brain metabolism
3brain atrophy
3biomarker
3balance
3atypical parkinsonism
3amyotrophic lateral sclerosis
3age of onset
3ablation
3Wolff–Parkinson–White syndrome
3Transplantation
3SPECT
3Progressive supranuclear palsy
3Positron emission tomography
3Parkin
3Neural transplantation
3Monoamine oxidase
3MAPT
3L‐dopa
3HPLC
3ECG
3Diffuse Lewy body disease
3DNA damage
3DJ‐1
3COMT inhibitors
3Basal ganglia
3Aging
3AV
36‐OHDA
2α‐ketoglutarate dehydrogenase
2working memory
2wearing off
2veterans
2ventral tegmental area
2urate
2trophic factors
2transplantation
2translational research
2tolerability
2thalamotomy
2telemedicine
2synucleinopathies
2survival
2surgery
2subthreshold depression
2subthalamic
2stem cell
2speech therapy
2spectroscopy
2signal transduction
2sialorrhea
2scales
2rotigotine
2ropinirole
2risk factor
2review
2retrorubral area
2research ethics
2rehabilitation
2randomized clinical trials
2radiofrequency catheter ablation
2questionnaire
2quantitative trait
2putamen
2pupil
2proteomics
2propafenone
2prognosis
2primate
2post‐mortem
2postural control
2population
2polymorphism
2plasticity
2placebo effects
2pharmacotherapy
2pathogenesis
2partial dopamine agonist
2parkinsonian disorders
2pancreatic islets
2outcomes research
2outcome measures
2nucleus accumbens
2norepinephrine
2non‐motor
2neurotrophic factor
2neurotransplantation
2neurofibrillary tangles
2neurodegenerative disease
2network analysis
2mutuality
2mouse
2motor
2motor symptoms
2motor neuron disease
2motor function
2motor control
2mode of inheritance
2mobility
2mitochondrial dysfunction
2missense mutation
2mild parkinsonian signs
2microtubule
2microelectrode recording
2methamphetamine
2magnetic resonance spectroscopy
2linkage analysis
2inflammation
2incidence
2impulse control disorders
2hypophonia
2hippocampus
2heterozygotes
2healthcare utilization
2hallucination
2glutathione
2glutamate receptor
2genetic testing
2genetic heterogeneity
2genes
2gene expression
2gender
2gait asymmetry
2freezing
2fatigue
2family‐based association analysis
2familial aggregation
2fMRI
2exercise
2executive functions
2executive function
2excessive daytime sleepiness
2estrogen
2epistasis
2electrocardiography
2efficacy
2effect size
2early stage PD
2dysautonomia
2dynamic posturography
2dopa‐responsive dystonia
2diffusion tensor imaging
2diabetes mellitus
2deletion
2decision analysis
2cycasin
2cycad
2creatine
2continuous dopaminergic stimulation
2complex I
2cohort study
2cognitive function
2coenzyme Q10
2clozapine
2clinical
2clinical phenotype
2cerebral blood flow
2cerebellum
2catechol‐O‐methyltransferase
2caspases
2case–control study
2carer
2cardiomyopathy
2cancer
2caffeine
2body mass index
2bilateral coordination
2autopsy
2autonomic failure
2autonomic dysfunction
2atypical antipsychotic
2atrial flutter
2astrocyte
2association studies
2assessment
2arrhythmias
2aripiprazole
2apoptosis
2apomorphine
2apolipoprotein E
2antioxidants
2antiarrhythmic drugs
2amygdala
2age at onset
2activities of daily living
2[18F]Fluorodeoxyglucose
2UCHL1
2Tyrosine hydroxylase
2Tremor
2SZ
2SNc
2RSV
2REM sleep behavior disorder
2Putamen
2Pramipexole
2Parkinson's disease/Parkinsonism
2Parkinson's disease with dementia
2Parkinson's disease (PD)
2Parkinson's Disease
2Pallidotomy
2Paired helical filament
2PGC‐1α
2PD, Parkinson’s disease
2PARK7
2PARK2
2Oxidative stress
2Olfaction
2O6-mdGuo
2Nurr1
2Neurotoxicity
2Neuroprotection
2Neuronal loss
2Neurofibrillary tangle
2Nerve growth factor
2NO
2NMU
2NMDA
2NIDDM
2Multiple sclerosis
2Motor control
2Mitochondria
2Markov
2Mahaim fibers
2MAO‐B inhibitors
2MAM
2Lewy body disease
2L-DOPA
2Immunocytochemistry
2IDDM
2Huntington disease
2Heart conduction system
2HVA
2Glutamate
2GPi
2G2019S
2Frontotemporal dementia
2Freezing
2Epidemiology
2Electrophysiology
2EDTA
2Diagnosis
2Dementia with Lewy bodies
2DOPAC
2DNA
2DBS
2DARPP-32
2Complex I
2Cerebrospinal fluid
2CS
2CNV
2Biomarkers
2Apoptosis
2Alzheimer's Disease
2Adenovirus
2AVNRT
2APOE
2ALS/PDC
25-HIAA
1“on‐off” phenomena types
1γ‐tubulin
1β‐synuclein
1β‐amyloid
1α‐synclein
1α‐Tocopherol
1α4β2 Nicotinic acetylcholine receptors
1α-Synuclein
1α-MPT
1zonisamide
1zonegran
1xenotransplantation
1wireless integrated circuit
1wide-complex tachycardia
1wide complex tachycardia
1whole genome association
1whole genome association study
1white matter lesions
1white matter hyperintensities
1weight loss
1wavefronts
1wasp venom
1washout
1walking economy
1voxel‐based morphometry
1volumetry
1volumetric MRI
1voltammetry
1vocal loudness
1vocal function
1vital status
1visual cueing
1vision
1videotape
1vesicular monoamine transporter
1verapamil
1ventricular enlargement
1ventral striatum
1ventral medial caudate
1ventral lateral caudate
1ventral intermedius
1venom
1vasculature
1vascular parkinsonism.
1vascular dementia
1variance‐component linkage analysis
1validation
1vagal nuclei
1utilization
1utilities
1use of cholinergic and dopaminergic agents
1urodynamics
1urban
1upper limb
1ubiquitination
1ubiquitin specific protease

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/Parkinson.storage/ParkinsonV1/Data/USA/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024